Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Sharma PS, Callans DJ.

J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep. Review.

2.

Cost-Effectiveness of Atrial Fibrillation Ablation.

Kudaiberdieva G, Gorenek B.

J Atr Fibrillation. 2013 Jun 30;6(1):880. doi: 10.4022/jafib.880. eCollection 2013 Jun-Jul. Review.

3.

Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Hassan OF, Al Suwaidi J, Salam AM.

J Atr Fibrillation. 2013 Jun 30;6(1):864. doi: 10.4022/jafib.864. eCollection 2013 Jun-Jul. Review.

4.

Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation.

Rillig A, Lin T, Ouyang F, Heinz Kuck K, Richard Tilz R.

J Atr Fibrillation. 2013 Jun 30;6(1):861. doi: 10.4022/jafib.861. eCollection 2013 Jun-Jul. Review.

5.

Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics.

Lee Park K, Anter E.

J Atr Fibrillation. 2013 Jun 30;6(1):751. doi: 10.4022/jafib.751. eCollection 2013 Jun-Jul. Review.

6.

Preventative Measures of Stroke in Patients With Atrial Fibrillation.

Adlan A, Yh Lip G.

J Atr Fibrillation. 2012 Apr 14;4(6):399. doi: 10.4022/jafib.399. eCollection 2012 Apr-May. Review.

7.

Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.

Johnson DL, Day JD, Mahapatra S, Bunch TJ.

J Atr Fibrillation. 2012 Feb 2;4(5):477. doi: 10.4022/jafib.477. eCollection 2012 Feb-Mar. Review.

8.

Atrial Fibrillation: a Patient's Guide to Understanding Drug Therapy.

Bhakta RS.

J Atr Fibrillation. 2008 Dec 1;1(4):146. doi: 10.4022/jafib.146. eCollection 2008 Dec. No abstract available.

9.

Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

Reiffel JA.

J Atr Fibrillation. 2008 May 16;1(1):21. doi: 10.4022/jafib.21. eCollection 2008 May-Jun. Review.

10.

Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease.

Choi DH, Kang SH, Song H.

Korean J Intern Med. 2016 Nov;31(6):1009-1017. Epub 2016 Oct 24. Review.

11.

A practical approach to the management of patients with atrial fibrillation.

McLeod CJ, Gersh BJ.

Heart Asia. 2010 Sep 6;2(1):95-103. doi: 10.1136/ha.2009.000596. eCollection 2010.

12.

Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Ogunsua AA, Shaikh AY, Ahmed M, McManus DD.

Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):228-34. doi: 10.14797/mdcj-11-4-228. Review.

13.

Current Evidence and Recommendations for Rate Control in Atrial Fibrillation.

Maan A, Mansour M, N Ruskin J, Heist EK.

Arrhythm Electrophysiol Rev. 2013 Apr;2(1):30-5. doi: 10.15420/aer.2013.2.1.30.

14.

Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction.

Virgadamo S, Charnigo R, Darrat Y, Morales G, Elayi CS.

World J Cardiol. 2015 Nov 26;7(11):808-16. doi: 10.4330/wjc.v7.i11.808.

15.

Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Holmes JW, Laksman Z, Gepstein L.

Prog Biophys Mol Biol. 2016 Jan;120(1-3):134-48. doi: 10.1016/j.pbiomolbio.2015.11.002. Epub 2015 Nov 23. Review.

16.

An International Observational Prospective Survey Assessing the Control of Atrial Fibrillation in Asia-Pacific: Results of the Record-AFAP Registry.

Amerena J, Chen SA, Sriratanasathavorn C, Cho JG, Dejia H, Omar R, Fat TH, King A.

Clin Med Insights Cardiol. 2015 Jul 27;9:77-83. doi: 10.4137/CMC.S22022. eCollection 2015.

17.

The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Darbar D.

J Cardiovasc Pharmacol. 2016 Jan;67(1):9-18. doi: 10.1097/FJC.0000000000000280. Review.

18.

Surgical options in atrial fibrillation.

Ramlawi B, Bedeir K.

J Thorac Dis. 2015 Feb;7(2):204-13. doi: 10.3978/j.issn.2072-1439.2014.12.34. Review.

19.

Decade-long trends in atrial fibrillation incidence and survival: a community study.

Chamberlain AM, Gersh BJ, Alonso A, Chen LY, Berardi C, Manemann SM, Killian JM, Weston SA, Roger VL.

Am J Med. 2015 Mar;128(3):260-7.e1. doi: 10.1016/j.amjmed.2014.10.030. Epub 2014 Nov 8.

20.

How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Sankaranarayanan R, Kirkwood G, Visweswariah R, Fox DJ.

Curr Cardiol Rev. 2015;11(3):190-8. Review.

Supplemental Content

Support Center